FDA Inspection 1165854 - Invitrx Therapeutics Inc. - March 22, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Invitrx Therapeutics Inc., with an inspection on March 22, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: Invitrx Therapeutics Inc.
Inspection Date: March 22, 2022
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · 6d1c02ea-ed52-43f5-be1c-143b4644fade

Violation Codes10

21 CFR 1271.180(a)21 CFR 1271.230(a)21 CFR 1271.265(c)(2)21 CFR 1271.50(a)21 CFR 211.100(a)21 CFR 211.101(b)21 CFR 211.110(b)21 CFR 211.113(b)21 CFR 211.160(b)21 CFR 211.166(a)

Full citation text and observation details available on the Dashboard.